Approval · Notice of Compliance 3723 · 1997
DILTIAZEM-CD: Notice of Compliance 3723
Issued June 27, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3723
- Date
- June 27, 1997
- Company
- Laboratoires Pro Doc Limitée
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Additional strengths
- Therapeutic class
- Antihypertensive agent, antianginal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DILTIAZEM-CD | 02231472 | Cancelled Post Market |
| DILTIAZEM-CD | 02231474 | Cancelled Post Market |
| DILTIAZEM-CD | 02231475 | Cancelled Post Market |
Medicinal ingredients
- DILTIAZEM HCL 120 MG per CAP
- DILTIAZEM HCL 180 MG per CAP
- DILTIAZEM HCL 240 MG per CAP